LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

Peak

lamivudine; tenofovir disoproxil fumarate

NDAORALTABLET
Approved
May 2018
Lifecycle
Peak
Competitive Pressure
30/100
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers